key: cord-0868522-lxizt9g9
authors: Yazdanpanah, Fariba; Asmarz, Hamid Yazdanpanah; Shadman, Shahrad
title: Multidimensional Literature Review of COVID-19, Pulmonary and Extrapulmonary Disease
date: 2021-02-04
journal: Am J Med Sci
DOI: 10.1016/j.amjms.2021.01.023
sha: 6aafc9955df830eaa32e5636f934557644860255
doc_id: 868522
cord_uid: lxizt9g9

In December 2019 novel coronavirus-Severe Acute Respiratory Syndrome-Corona Virus2 (SARS-CoV2)-originated from Wuhan, China, and spread rapidly around the world. This literature review highlights the dynamic nature of COVID-19 transmission and presentation. Analyzing 59 relevant articles up to May 1(st), 2020 reflects that the main reported clinical manifestation of COVID-19 pandemic is fever and respiratory involvement. Also, current literature demonstrates a wide spectrum of different and atypical presentation(s) of COVID-19. The definite route of SARS-CoV2 transmission is respiratory droplets, however, virus nucleic acid has been detected in the stool and urine specimens as well. The severity of symptoms and outcomes of COVID-19 vary based on the patient's medical background, age, sex, and concurrent medical conditions (e.g. pregnancy). This is the first review that classifies all essential points regarding COVID-19 manifestations at a glance to improve the outcome of the patients by a better insight into diagnosis and management.

Coronaviruses (CoVs) a large family of Coronavirinae affecting both humans and animals. The first human CoV (HCoV) was identified in the mid-1960s in human embryonic tracheal organ cultures and until 2003 only two HCoV species, HCoV-229E, and HCoV-OC43, were recognized.

To date, six HCoVs have been identified, Severe Acute Respiratory Syndrome-Corona Virus2 (SARS-CoV2) is classified into the beta-CoVs group (Chart 1). Before the last two lethal outbreaks of HCoVs by Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) these viruses were considered relatively benign (1, 2) . Table 1 compares some of the specifications of three lethal human coronaviruses (HCoVs).

Coronavirus family is spherical, enveloped, non-segmented, single-strand, positive-sense RNA with a large known genome, of 30-32 kb. The "crown-like" spikes on the outer edge of its surface give the coronaviruses its name -the virus wears a crown (6) .

Infection by SARS-CoV2 (the initial name was 2019-nCOV) causes Coronavirus Disease 2019 which is transmitted through large droplets generated during coughing and sneezing by either symptomatic patients or asymptomatic people. The incubation period of COVID-19 varies from 2-14 days. Virus sneaks into respiratory cells (type 2 pneumonocytes and ciliated bronchial epithelial cells) via attachment between Angiotensin-Converting Enzyme 2 (ACE2) receptors and Spike Glycoprotein (S Glycoprotein) (7) .

The most common initial clinical manifestations of COVID-19 include fever (82%), cough (61%), myalgia and/or fatigue (36%), shortness of breath (26%), headache (12%), sore throat (10%) and gastrointestinal symptoms (9%). Laboratory findings are different from normal findings to lymphopenia (0.93 x 10 9 /L) and abnormal C -reactive protein (33.72 mg/dL). According to a retrospective review on 25 death cases of COVID-19, an elevated level of neutrophils, Serum Amyloid A (SAA), Procalcitonin (PCT), C-Reactive Protein (CRP), Troponin I (cTnI), D-Dimer and Lactate Dehydrogenase (LDH) can be considered as factors of disease progression (8, 9) . Also, a case report study mentioned that decreased plasma level of albumin (Hypoalbuminemia) is another identified marker of critical illness in COVID-19 patients. The most described radiological findings in COVID-19 pneumonia are consolidation and bilateral multilobar groundglass opacification (GGO) with a peripheral or posterior distribution, mainly in the lower lobes and less frequently within the right middle lobe (8, 10, 11) .

For the diagnosis in patients with suspected infection, the following procedures are recommended: Real-Time Polymerase Chain Reaction (RT-PCR) to detect the positive nucleic acid of SARS-CoV2 in sputum, nasopharyngeal swab, and secretions of the lower respiratory tract samples, while viral nucleic acids are detectable in blood and digestive tract (fecal/anal swabs) as well. Multi-sample nucleic acid detection is preferable to a single sample method and could improve accuracy, reduces the false-negative rate, provides a better guide for clinical treatment, and evaluating the therapeutic effect (12, 13) .

Given the clinical feature of SARS-CoV2 infection varies from an asymptomatic state to a wide spectrum of clinical presentations this multidimensional review article conducted to integrate and summarize the novel and rare information about COVID-19 manifestations which have been reported up to May 1 st , 2020. Also, this review contains different clinical situations that might be affected by SARS-CoV2 infection such as pregnancy and breastfeeding. We also focused on clinical differences at both ends of the age in this review.

To comprise this review article our team assessed 59 accessible articles about COVID-19 in the current literature. We leaned on qualitative, non-statistical tools for consolidating, evaluating, and interpreting the results of the conducted papers. In the following, we explain what strategy we used in our methodology.

First, by focusing on various reports about COVID-19 manifestations and engaging in relevant current articles we formulated the research scope before beginning the review process.

For selecting studies we conducted a systematic search via Google engine and PubMed database which is a widely used search engine, founded and maintained by the United States National Center for Biotechnology Information (NCBI) at the US National Library of Medicine (NLM) (14) . The following keywords have been used: "COVID-19" OR "2019 novel coronavirus" OR "2019-nCoV" OR "SARS-CoV-2" OR "Wuhan coronavirus" AND "presentation" OR "characteristic" OR "manifestations". After finding relevant studies to our literature review, we carefully screened studies that met the formulated inclusion criteria including 1) case reports, case series, cohort studies and reviews (literature review, systematic review, and meta-analysis) that considered COVID-19 manifestations 2) current and retrospective studies about SARS-CoV2's impact on specific organ systems 3) clinical differences of COVID-19 in particular groups including children, senile people, pregnant women, and breastfeeding mothers. 

In this step, we extracted data by specifying relevant study components including the country of the study, date of the study, type of the study, patient age range, patient medical status, and symptoms category (respiratory, GI, cardiovascular, etc.). Review of the articles and data collection has been performed by two researchers of our team separately but the possibility of publication bias cannot be ruled out.

SARS-COV2 represents the causal agent of a potentially fatal disease (COVID-19) that is actually of great global public health concern. COVID-19 disease initially began in the form of unexplained pneumonia in Wuhan, Hubei Province, China in December 2019 and rapidly spread to many countries around the globe; On March 12 th , 2020, the World Health Organization (WHO) declared that the COVID-19 constitutes a pandemic.

As of April 5 th , 2020, 1,218,090 confirmed cases of COVID-19 with 65,836 deaths (Case Fatality Rate: 5.4%) has been reported (15) . Given a study on April 16 th , 2020, the case fatality rate (CFR) varied between 0.08 -10.8% for 65 countries (16) . Based on the "worldmeters.info" 

The involvement of the lower respiratory tract by SARS-CoV2 is varied, ranging from asymptomatic carriers to pneumonia and acute respiratory distress syndrome (ARDS).

According to different studies, the median time from onset of symptoms to dyspnea is 5 days, hospitalization 7 days, and acute respiratory distress syndrome (ARDS) 3-8 days. A pooled analysis of 468 patients with pneumonia reported 70.9% of patients required oxygen therapy, 28 .8% needed mechanical ventilation, 3.1% of patients required extracorporeal membrane oxygenation (ECMO), and the overall mortality was 8.2% (10, 17, 18) . 

Along with the respiratory system, the GI tract is another system that frequently involves in the COVID-19 course; however, some patients can present with digestive symptoms in the absence of respiratory symptoms. Mostly incidence of digestive manifestations is higher in the later than in the early stage of the disease. Also, in patients with higher disease severity liver injury is more common, so monitoring of liver function in the course of the disease is recommended.

Another important point about GI tract involvement is the shedding of SARS-CoV2 into feces which implicates the possibility of fecal-oral transmission (20, 21) . Liver damage presents with elevated serum liver biochemistries in hospitalized patients with SARS-CoV2 infection. The incidence of rising serum levels of AST, ALT, and Bilirubin ranges from 14-53%. Men and more severe cases of COVID-19 are more predisposed to increased liver enzymes. Also, a low albumin level is associated with severe infection and poor prognosis; therefore regular monitoring of liver biochemistries should be performed in all COVID-19 patients (15).

SARS-CoV2 has significant implications for the cardiovascular care of patients. First, the virus has a direct and indirect effect on the CV system that could cause complications such as Acute The level of cardiac troponin T (cTnT) is another important predictive factor in patients with SARS-CoV2. Higher levels of cTnT associated with a higher level of N-terminal pro-brain natriuretic peptide (NT-proBNP) and also higher incidence of complications such as ARDS, malignant cardiac arrhythmias, acute kidney injury (AKI), acute coagulopathy as well as higher mortality rates. The mortality during hospitalization for patients without underlying CVD and normal cTnT was significantly lower than patients with underlying CVD and elevated cTnT (7.62% vs. 69.44%) (31). Another important point about the interaction between SARS-CoV2 and neurology system is the outcome of COVID-19 in patients with pre-existing neurology disorders. According to available reviews, cerebrovascular disease is one of the underlying conditions with a negative impact on the clinical course of SARS-CoV2 infection and could increase the mortality rate (1, 4, 19) .

There is not much data available about the involvement of the renal system in the course of SARS-CoV2 infection. The most common renal manifestation of COVID-19 is Acute Kidney Injury presentations. Ageusia and anosmia in COVID-19 are not associated with nasal obstruction or any other forms of rhinitis; therefore, the possible mechanism would be sensorineural dysfunction which is caused by direct damage to the olfactory and gustatory receptors by SARS-CoV2 (34, 43) .

In dental care setting, due to the specificity of the procedures which involve face-to-face communication with patients, frequent exposure to saliva and blood, and the handling of sharp instruments, the risk of infection is very high. The New York Times published an article on March 15 th , 2020, entitled "The Workers Who Face the Greatest Coronavirus Risk". This article with an impressive schematic figure explains "dentists" as healthcare workers who are most exposed to the risk of being affected by SARS-CoV2, even much more than nurses and general physicians. The most recommended guidelines by some organizations, such as The National

Health Surveillance Agency in Brazil is indicated only emergency and urgent dental care should be performed during the COVID-19 pandemic. Also, universal precautions and the management practice for the staffs are quite similar to what takes place in other highly contagious circumstances such as careful sterilization and disinfection of patient-care items, safe injection practice, using personal protective equipment (PPE), working at an acceptable distance from the patients -as often as possible -and equipping handpieces with anti-reflux devices to avoid contaminations. Finally, the dentists should also prefer to choose methods of surgery that are associated with less aerosol production in the environment (44, 45) .

Transmission of SARS-CoV2 through mucous membranes like conjunctival epithelium is an important source of infection. The fact that Infectious droplets and body fluid can easily contaminate the exposed and unprotected mucous membranes (eyes, mouth, and nose) suggests that eye contact with SARS-CoV2 can cause acute respiratory infection. Different 

Dermatologists are at risk for SARS-CoV2 infection due to the close contact with the skin and the mucosa. According to the literature knowledge, 20% of COVID-19 patients showed nonspecific skin lesions such as erythematous rash, petechia, urticaria, and vesicles. Also, different skin conditions have emerged mainly as a result of prolonged contact with PPE and excessive personal hygiene including pressure injury, contact dermatitis, facial inflammatory papules, itch, pressure urticaria, and exacerbation of pre-existing skin disease such as seborrheic dermatitis, rosacea, and acne. Besides all skin lesions listed above, hyperhidrosis has been reported in 75% of Chinese health care workers involved in care for COVID-19 patients; this may result in a higher risk for non-diphtheroid corynebacterial disorders, other bacterial infections, and tinea. On the other hand, exaggerated hand washing with detergents/disinfectants can destroy the hydro-lipid cover of the skin surface and may cause irritation and even the development of contact dermatitis. Therefore, the use of preventive measures such as emollients, barrier creams, and moisturizers, is essential to prevent skin lesions during the COVID-19 pandemic (50-52).

Given the previous epidemics (SARS-CoV and MERS-CoV), as well as mental and physical changes during pregnancy, pregnant women are a vulnerable group to be affected by the virus.

The findings of current studies do not report convincing evidence related to vertical transmission of SARS-CoV2 during delivery and breast milk from mother to fetus. The type of delivery, whether a cesarean section or normal vaginal delivery (NVD) in infected mothers with SARS-CoV2, does not show any impact on fetus involvement. However, according to some studies, a mother's infection with SARS-CoV2 during pregnancy can cause complications for both the mother and the fetus, including miscarriage, fetal distress, preterm delivery, respiratory distress, coagulopathy accompanied by liver dysfunction, and death of the mother but does not infect the newborn; thus monitoring suspected pregnant women is essential.

Based on reported cases, all neonates with confirmed COVID-19 had been infected after birth via cough of the mother or other relatives, or through the infected environment. The average time of symptoms presentation in infants was between 5 to 17 days after birth. The most common sign and symptoms of SARS-CoV2 in infected infants were reported as tachypnea, milk regurgitation, vomiting, cough, fever, pneumothorax, liver disorders, thrombocytopenia, and pulmonary changes in chest CT scan. In terms of mother-newborn bonding and breastfeeding, 

The data show that the prevalence of SARS-CoV2 infection in children ≤ 18 years of age is 

Senile men with chronic comorbidities are more likely to get infected with SARS-CoV2. They also have a higher risk of developing complications of COVID-19, including ARDS, ACI, AKI, and liver injury. Different studies demonstrated identical initial presentations of SARS-CoV2 infection in both the elderly and younger ages. The most common symptoms in the elderly were fever followed by cough, dyspnea, and fatigue; but the Pneumonia Severity Index (PSI) score of the elderly group was higher compared to the young and middle-aged group. In terms of laboratory findings in the elderly, lymphocytopenia was a common laboratory finding, and also the proportion of lymphocytes in the investigated elderly group was significantly lower than the younger age. The C -reactive protein (CRP) level was significantly higher than younger and middle-aged patients. A study by Liu et al. reported no significant differences in neutrophil ratio, procalcitonin, hemoglobin level, platelet count, and serum creatinine level in elderly vs. young patients (3, 60, 61) .

In terms of Imaging findings of SARS-CoV2 in the elderly, patients older than 60 years old showed more extensive ground-glass opacification (GGO), a higher proportion of multiple lobes involvement, and also more atypical findings in the chest CT workup (11, 60) .

Regarding the predictors of COVID-19 outcome in elderly, an investigation on 339 patients with a mean age of 71 years in Renmin Hospital of Wuhan University declares that the symptom of dyspnea, presence of comorbidities (CVD, Chronic Obstructive Pulmonary Disease), and occurrence of complications such as ARDS in the course of the disease, are strong predictors of death in senile patients. On the other hand, a high level of lymphocytes was predictive of a better outcome of SARS-CoV2 in this group. Regardless of the determinants listed above, the current literature reflects "age" itself can complicate the course of the disease, so that the mortality rate in patients ≥60 years old reaches 8.8% compared to 0.46% for patients <60 years old. Therefore, "age" is one of the key factors in predicting the outcome of COVID-19 and should be considered as an independent variable in COVID-19 mortality (4,61).

To our knowledge, this is the first literature review that summarized and classified a variety of symptoms of COVID-19 at a glance. Current evidence is mostly documented from Chinese studies where COVID-19 originated. Our research demonstrates that SARS-CoV2 infection has a dynamic nature of the presentation and disease severity varies based on the patient's medical background, age, sex, and concurrent medical conditions (e.g. pregnancy). We believe this study provides essential and recent clinical information on different aspects of COVID-19 manifestation to help healthcare professionals raise awareness about the disease course in order to improve outcomes by a better insight into diagnosis and management and consequently prevention of higher health and economic costs. However, because of the rapid spread of the virus globally and the dynamic nature of the disease, the reported evidence might be subject to change in the future when further knowledge will be acquired about the COVID-19 pandemic. 

Potential Effects of Coronaviruses on the Cardiovascular System: A Review

The Novel Coronavirus: A Bird's Eye View

The SARS-CoV-2 Outbreak: What We Know

A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Coronavirus Pathogenesis

Novel Coronavirus: Where We Are and What We Know

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis2020

Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center

Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness fromCOVID-19 Infection

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Detection and Analysis of Nucleic Acid in Various Biological Samples of COVID-19 Patients

Epidemiology, Causes, Clinical Manifestation and Diagnosis, Prevention and Control of Coronavirus Disease (COVID-19) During the Early Outbreak Period: A Scoping Review

Best Match: New relevance search for PubMed

COVID-19 and liver disease

Flattening-the-curve Associated With Reduced COVID-19 Case Fatality Rates-An Ecological Analysis of 65 Countries

A Review of Coronavirus Disease-2019 (COVID-19)

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths

Clinical characteristics of 2019 novel coronavirus infection in China

Gastrointestinal and Liver Manifestations in Patients with COVID

Online ahead of print

Review Article: Gastrointestinal Features in COVID-19 and the Possibility of Faecal Transmission

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis

Associated With Acute Respiratory Distress Syndrome

COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis

Underlying Disorders and Their Impact on the Host Response to Infection

Cardiovascular disease and COVID-19

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Neurological Manifestations of the Coronavirus (SARS-CoV-2) Pandemic 2019-2020

Neurological Complications of Coronavirus Disease

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Neurologic manifestations in an infant with COVID-19

Kidney Involvement in COVID-19 and Rationale for Extracorporeal Therapies

Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

Persistence and Clearance of Viral RNA in

Novel Coronavirus Disease Rehabilitation Patients

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab

Aerosol and Surface Stability of SARS-CoV-2 as Compared With SARS-CoV-1

COVID-19 and Urology: A Comprehensive Review of the Literature

Anosmia and Ageusia: Common Findings in COVID-19

Online ahead of print

COVID-19 Outbreak: An Overview on Dentistry

Coronavirus Disease (COVID-19): Characteristics in children and considerations for Dentists providing their care

2019-nCoV transmission through the ocular surface must not be ignored

Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals

Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear

Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19

Coronavirus-days in Dermatology

Challenges of Covid-19 Pandemic for Dermatology

Covid-19 pandemic and the skin -What should dermatologists know?

Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review

Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies. Matern Child Nutr

Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

COVID-19 epidemic: disease characteristics in children

Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

HCoVs-HKU1

HCoVs-NL63

HCoVs alpha-CoVs